Yes it is “outrageous” how JP and his team has kept every essential deadline since the deal was made with Acadia and has informed us every step along the path until fda approval on the due date. For ROWR he has consistently said that they are working towards the best outcome for shareholders…. which is still progressing.
I just reread the investor review given two days after the fda approval and it was excellent.
We will get another update soon. Payment of the 40 million and/or ROWr update and/or Phase 2 update(s) and/or investigation into another area.
What I personally do not want is a takeover.
Pending ROW deal??, page-130
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.08 |
Change
-0.640(3.09%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $2.168M | 107.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 192 | $20.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.09 | 49 | 2 |
View Market Depth
| Last trade - 12.27pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |